Global Platelet Function Testing Market
Global Platelet Function Testing Market

Platelet Function Testing Comprehensive Study by Type (Systems, Reagents, Accessories), Application (Research, Pharmaceutical Development, Others), Testing Type (Light Transmission Aggregometry (LTA), Vasodilator-Stimulated Phosphoprotein (VASP), Multiplate Analyzer (Multiple Electrode Aggregometry (MEA))), End-Use (Hospitals, Blood Banks, Diagnostic Centers, Academic Institutions, Others) Players and Region - Global Market Outlook to 2025

Platelet Function Testing Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 248 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Platelet Function Testing Market Overview:
Cardiovascular diseases are the leading cause of death in the Western world. Several factors have led to the increase in vascular disorders, including the aging population, unhealthy lifestyles, increasing rates of diabetes and raised lipids, and further risk factors resulting in inflammation and calcification of the vascular endothelium. Platelets are an essential component of blood coagulation and are responsible for maintaining primary hemostasis under conditions of blood flow. There are several methods for platelet function testing (PFT), which differ with regard to the underlying detection principle, agonists, and sample material used for testing.

Growth Drivers
  • Increasing Vascular Disorders, including Aging Population, Unhealthy Lifestyles, Increasing Rates of Diabetes and Others
  • Growing Awareness about the Platelet Rich Plasma Therapy

Market Trends
  • Increasing Investment in R&D
  • Adoption of Technologically Advanced product in Platelet Aggregation System


Opportunities
  • Growing Number of Surgical Procedures

Challenges
  • High Costs of Therapies and Devices Can Hamper the Growth of Market


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are F. Hoffmann-La Roche Ltd (Switzerland), Fresenius (Germany), Siemens (Germany), TERUMO BCT, INC. (United States), Haemonetics Corporation (United States), AggreDYNE (United States), Helena Laboratories (United States), Sysmex Corporation (Japan), Haemochrom Diagnostica GmbH (Germany), Pathway Diagnostics Limited (United Kingdom), LABiTec LAbor BioMedical Technologies GmbH (Germany), Thermo Fisher Scientific (United States), Quest Diagnostics Incorporated (United States) and PerkinElmer Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like WerfenLife, S.A. (Spain), Matis Medical Inc. (United States), Chrono-log Corporation (United States) and Drucker Diagnostics (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Platelet Function Testing market by 2025. Considering Market by Testing Type, the sub-segment i.e. Light Transmission Aggregometry (LTA) will boost the Platelet Function Testing market. Considering Market by End-Use, the sub-segment i.e. Hospitals will boost the Platelet Function Testing market.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Platelet Function Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Platelet Function Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Platelet Function Testing Service Providers, Healthcare Industry, Regulatory Bodies, Clinical Laboratory and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Systems
  • Reagents
  • Accessories
By Application
  • Research
  • Pharmaceutical Development
  • Others
By Testing Type
  • Light Transmission Aggregometry (LTA)
  • Vasodilator-Stimulated Phosphoprotein (VASP)
  • Multiplate Analyzer [Multiple Electrode Aggregometry (MEA)]

By End-Use
  • Hospitals
  • Blood Banks
  • Diagnostic Centers
  • Academic Institutions
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Vascular Disorders, including Aging Population, Unhealthy Lifestyles, Increasing Rates of Diabetes and Others
      • 3.2.2. Growing Awareness about the Platelet Rich Plasma Therapy
    • 3.3. Market Challenges
      • 3.3.1. High Costs of Therapies and Devices Can Hamper the Growth of Market
    • 3.4. Market Trends
      • 3.4.1. Increasing Investment in R&D
      • 3.4.2. Adoption of Technologically Advanced product in Platelet Aggregation System
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Platelet Function Testing, by Type, Application, Testing Type, End-Use and Region (value and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Platelet Function Testing (Value)
      • 5.2.1. Global Platelet Function Testing by: Type (Value)
        • 5.2.1.1. Systems
        • 5.2.1.2. Reagents
        • 5.2.1.3. Accessories
      • 5.2.2. Global Platelet Function Testing by: Application (Value)
        • 5.2.2.1. Research
        • 5.2.2.2. Pharmaceutical Development
        • 5.2.2.3. Others
      • 5.2.3. Global Platelet Function Testing by: Testing Type (Value)
        • 5.2.3.1. Light Transmission Aggregometry (LTA)
        • 5.2.3.2. Vasodilator-Stimulated Phosphoprotein (VASP)
        • 5.2.3.3. Multiplate Analyzer [Multiple Electrode Aggregometry (MEA)]
      • 5.2.4. Global Platelet Function Testing by: End-Use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Blood Banks
        • 5.2.4.3. Diagnostic Centers
        • 5.2.4.4. Academic Institutions
        • 5.2.4.5. Others
      • 5.2.5. Global Platelet Function Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Platelet Function Testing (Price)
      • 5.3.1. Global Platelet Function Testing by: Type (Price)
  • 6. Platelet Function Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Fresenius (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. TERUMO BCT, INC. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Haemonetics Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AggreDYNE (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Helena Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sysmex Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Haemochrom Diagnostica GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pathway Diagnostics Limited (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. LABiTec LAbor BioMedical Technologies GmbH (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Thermo Fisher Scientific (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Quest Diagnostics Incorporated (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. PerkinElmer Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Platelet Function Testing Sale, by Type, Application, Testing Type, End-Use and Region (value and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Platelet Function Testing (Value)
      • 7.2.1. Global Platelet Function Testing by: Type (Value)
        • 7.2.1.1. Systems
        • 7.2.1.2. Reagents
        • 7.2.1.3. Accessories
      • 7.2.2. Global Platelet Function Testing by: Application (Value)
        • 7.2.2.1. Research
        • 7.2.2.2. Pharmaceutical Development
        • 7.2.2.3. Others
      • 7.2.3. Global Platelet Function Testing by: Testing Type (Value)
        • 7.2.3.1. Light Transmission Aggregometry (LTA)
        • 7.2.3.2. Vasodilator-Stimulated Phosphoprotein (VASP)
        • 7.2.3.3. Multiplate Analyzer [Multiple Electrode Aggregometry (MEA)]
      • 7.2.4. Global Platelet Function Testing by: End-Use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Blood Banks
        • 7.2.4.3. Diagnostic Centers
        • 7.2.4.4. Academic Institutions
        • 7.2.4.5. Others
      • 7.2.5. Global Platelet Function Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Platelet Function Testing (Price)
      • 7.3.1. Global Platelet Function Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Platelet Function Testing: by Type(USD Million)
  • Table 2. Platelet Function Testing Systems , by Region USD Million (2014-2019)
  • Table 3. Platelet Function Testing Reagents , by Region USD Million (2014-2019)
  • Table 4. Platelet Function Testing Accessories , by Region USD Million (2014-2019)
  • Table 5. Platelet Function Testing: by Application(USD Million)
  • Table 6. Platelet Function Testing Research , by Region USD Million (2014-2019)
  • Table 7. Platelet Function Testing Pharmaceutical Development , by Region USD Million (2014-2019)
  • Table 8. Platelet Function Testing Others , by Region USD Million (2014-2019)
  • Table 9. Platelet Function Testing: by Testing Type(USD Million)
  • Table 10. Platelet Function Testing Light Transmission Aggregometry (LTA) , by Region USD Million (2014-2019)
  • Table 11. Platelet Function Testing Vasodilator-Stimulated Phosphoprotein (VASP) , by Region USD Million (2014-2019)
  • Table 12. Platelet Function Testing Multiplate Analyzer [Multiple Electrode Aggregometry (MEA)] , by Region USD Million (2014-2019)
  • Table 13. Platelet Function Testing: by End-Use(USD Million)
  • Table 14. Platelet Function Testing Hospitals , by Region USD Million (2014-2019)
  • Table 15. Platelet Function Testing Blood Banks , by Region USD Million (2014-2019)
  • Table 16. Platelet Function Testing Diagnostic Centers , by Region USD Million (2014-2019)
  • Table 17. Platelet Function Testing Academic Institutions , by Region USD Million (2014-2019)
  • Table 18. Platelet Function Testing Others , by Region USD Million (2014-2019)
  • Table 19. South America Platelet Function Testing, by Country USD Million (2014-2019)
  • Table 20. South America Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 21. South America Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 22. South America Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 23. South America Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 24. Brazil Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 25. Brazil Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 26. Brazil Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 27. Brazil Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 28. Argentina Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 29. Argentina Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 30. Argentina Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 31. Argentina Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 32. Rest of South America Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 33. Rest of South America Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 34. Rest of South America Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 35. Rest of South America Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 36. Asia Pacific Platelet Function Testing, by Country USD Million (2014-2019)
  • Table 37. Asia Pacific Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 38. Asia Pacific Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 39. Asia Pacific Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 40. Asia Pacific Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 41. China Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 42. China Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 43. China Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 44. China Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 45. Japan Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 46. Japan Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 47. Japan Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 48. Japan Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 49. India Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 50. India Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 51. India Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 52. India Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 53. South Korea Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 54. South Korea Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 55. South Korea Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 56. South Korea Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 57. Taiwan Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 58. Taiwan Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 59. Taiwan Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 60. Taiwan Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 61. Australia Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 62. Australia Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 63. Australia Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 64. Australia Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 65. Rest of Asia-Pacific Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 66. Rest of Asia-Pacific Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 67. Rest of Asia-Pacific Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 68. Rest of Asia-Pacific Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 69. Europe Platelet Function Testing, by Country USD Million (2014-2019)
  • Table 70. Europe Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 71. Europe Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 72. Europe Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 73. Europe Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 74. Germany Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 75. Germany Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 76. Germany Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 77. Germany Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 78. France Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 79. France Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 80. France Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 81. France Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 82. Italy Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 83. Italy Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 84. Italy Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 85. Italy Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 86. United Kingdom Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 87. United Kingdom Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 88. United Kingdom Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 89. United Kingdom Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 90. Netherlands Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 91. Netherlands Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 92. Netherlands Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 93. Netherlands Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 94. Rest of Europe Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 95. Rest of Europe Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 96. Rest of Europe Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 97. Rest of Europe Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 98. MEA Platelet Function Testing, by Country USD Million (2014-2019)
  • Table 99. MEA Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 100. MEA Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 101. MEA Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 102. MEA Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 103. Middle East Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 104. Middle East Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 105. Middle East Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 106. Middle East Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 107. Africa Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 108. Africa Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 109. Africa Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 110. Africa Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 111. North America Platelet Function Testing, by Country USD Million (2014-2019)
  • Table 112. North America Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 113. North America Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 114. North America Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 115. North America Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 116. United States Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 117. United States Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 118. United States Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 119. United States Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 120. Canada Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 121. Canada Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 122. Canada Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 123. Canada Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 124. Mexico Platelet Function Testing, by Type USD Million (2014-2019)
  • Table 125. Mexico Platelet Function Testing, by Application USD Million (2014-2019)
  • Table 126. Mexico Platelet Function Testing, by Testing Type USD Million (2014-2019)
  • Table 127. Mexico Platelet Function Testing, by End-Use USD Million (2014-2019)
  • Table 128. Platelet Function Testing: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Platelet Function Testing: by Type(USD Million)
  • Table 144. Platelet Function Testing Systems , by Region USD Million (2020-2025)
  • Table 145. Platelet Function Testing Reagents , by Region USD Million (2020-2025)
  • Table 146. Platelet Function Testing Accessories , by Region USD Million (2020-2025)
  • Table 147. Platelet Function Testing: by Application(USD Million)
  • Table 148. Platelet Function Testing Research , by Region USD Million (2020-2025)
  • Table 149. Platelet Function Testing Pharmaceutical Development , by Region USD Million (2020-2025)
  • Table 150. Platelet Function Testing Others , by Region USD Million (2020-2025)
  • Table 151. Platelet Function Testing: by Testing Type(USD Million)
  • Table 152. Platelet Function Testing Light Transmission Aggregometry (LTA) , by Region USD Million (2020-2025)
  • Table 153. Platelet Function Testing Vasodilator-Stimulated Phosphoprotein (VASP) , by Region USD Million (2020-2025)
  • Table 154. Platelet Function Testing Multiplate Analyzer [Multiple Electrode Aggregometry (MEA)] , by Region USD Million (2020-2025)
  • Table 155. Platelet Function Testing: by End-Use(USD Million)
  • Table 156. Platelet Function Testing Hospitals , by Region USD Million (2020-2025)
  • Table 157. Platelet Function Testing Blood Banks , by Region USD Million (2020-2025)
  • Table 158. Platelet Function Testing Diagnostic Centers , by Region USD Million (2020-2025)
  • Table 159. Platelet Function Testing Academic Institutions , by Region USD Million (2020-2025)
  • Table 160. Platelet Function Testing Others , by Region USD Million (2020-2025)
  • Table 161. South America Platelet Function Testing, by Country USD Million (2020-2025)
  • Table 162. South America Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 163. South America Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 164. South America Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 165. South America Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 166. Brazil Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 167. Brazil Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 168. Brazil Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 169. Brazil Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 170. Argentina Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 171. Argentina Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 172. Argentina Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 173. Argentina Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 174. Rest of South America Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 175. Rest of South America Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 176. Rest of South America Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 177. Rest of South America Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 178. Asia Pacific Platelet Function Testing, by Country USD Million (2020-2025)
  • Table 179. Asia Pacific Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 180. Asia Pacific Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 181. Asia Pacific Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 182. Asia Pacific Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 183. China Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 184. China Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 185. China Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 186. China Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 187. Japan Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 188. Japan Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 189. Japan Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 190. Japan Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 191. India Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 192. India Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 193. India Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 194. India Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 195. South Korea Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 196. South Korea Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 197. South Korea Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 198. South Korea Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 199. Taiwan Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 200. Taiwan Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 201. Taiwan Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 202. Taiwan Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 203. Australia Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 204. Australia Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 205. Australia Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 206. Australia Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 207. Rest of Asia-Pacific Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 208. Rest of Asia-Pacific Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 209. Rest of Asia-Pacific Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 210. Rest of Asia-Pacific Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 211. Europe Platelet Function Testing, by Country USD Million (2020-2025)
  • Table 212. Europe Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 213. Europe Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 214. Europe Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 215. Europe Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 216. Germany Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 217. Germany Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 218. Germany Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 219. Germany Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 220. France Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 221. France Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 222. France Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 223. France Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 224. Italy Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 225. Italy Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 226. Italy Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 227. Italy Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 228. United Kingdom Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 229. United Kingdom Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 230. United Kingdom Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 231. United Kingdom Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 232. Netherlands Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 233. Netherlands Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 234. Netherlands Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 235. Netherlands Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 236. Rest of Europe Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 237. Rest of Europe Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 238. Rest of Europe Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 239. Rest of Europe Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 240. MEA Platelet Function Testing, by Country USD Million (2020-2025)
  • Table 241. MEA Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 242. MEA Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 243. MEA Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 244. MEA Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 245. Middle East Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 246. Middle East Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 247. Middle East Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 248. Middle East Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 249. Africa Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 250. Africa Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 251. Africa Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 252. Africa Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 253. North America Platelet Function Testing, by Country USD Million (2020-2025)
  • Table 254. North America Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 255. North America Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 256. North America Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 257. North America Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 258. United States Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 259. United States Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 260. United States Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 261. United States Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 262. Canada Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 263. Canada Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 264. Canada Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 265. Canada Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 266. Mexico Platelet Function Testing, by Type USD Million (2020-2025)
  • Table 267. Mexico Platelet Function Testing, by Application USD Million (2020-2025)
  • Table 268. Mexico Platelet Function Testing, by Testing Type USD Million (2020-2025)
  • Table 269. Mexico Platelet Function Testing, by End-Use USD Million (2020-2025)
  • Table 270. Platelet Function Testing: by Type(USD/Units)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Platelet Function Testing: by Type USD Million (2014-2019)
  • Figure 5. Global Platelet Function Testing: by Application USD Million (2014-2019)
  • Figure 6. Global Platelet Function Testing: by Testing Type USD Million (2014-2019)
  • Figure 7. Global Platelet Function Testing: by End-Use USD Million (2014-2019)
  • Figure 8. South America Platelet Function Testing Share (%), by Country
  • Figure 9. Asia Pacific Platelet Function Testing Share (%), by Country
  • Figure 10. Europe Platelet Function Testing Share (%), by Country
  • Figure 11. MEA Platelet Function Testing Share (%), by Country
  • Figure 12. North America Platelet Function Testing Share (%), by Country
  • Figure 13. Global Platelet Function Testing: by Type USD/Units (2014-2019)
  • Figure 14. Global Platelet Function Testing share by Players 2019 (%)
  • Figure 15. Global Platelet Function Testing share by Players (Top 3) 2019(%)
  • Figure 16. Global Platelet Function Testing share by Players (Top 5) 2019(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2019
  • Figure 20. Fresenius (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Fresenius (Germany) Revenue: by Geography 2019
  • Figure 22. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Siemens (Germany) Revenue: by Geography 2019
  • Figure 24. TERUMO BCT, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 25. TERUMO BCT, INC. (United States) Revenue: by Geography 2019
  • Figure 26. Haemonetics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Haemonetics Corporation (United States) Revenue: by Geography 2019
  • Figure 28. AggreDYNE (United States) Revenue, Net Income and Gross profit
  • Figure 29. AggreDYNE (United States) Revenue: by Geography 2019
  • Figure 30. Helena Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 31. Helena Laboratories (United States) Revenue: by Geography 2019
  • Figure 32. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Sysmex Corporation (Japan) Revenue: by Geography 2019
  • Figure 34. Haemochrom Diagnostica GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Haemochrom Diagnostica GmbH (Germany) Revenue: by Geography 2019
  • Figure 36. Pathway Diagnostics Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. Pathway Diagnostics Limited (United Kingdom) Revenue: by Geography 2019
  • Figure 38. LABiTec LAbor BioMedical Technologies GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 39. LABiTec LAbor BioMedical Technologies GmbH (Germany) Revenue: by Geography 2019
  • Figure 40. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 41. Thermo Fisher Scientific (United States) Revenue: by Geography 2019
  • Figure 42. Quest Diagnostics Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 43. Quest Diagnostics Incorporated (United States) Revenue: by Geography 2019
  • Figure 44. PerkinElmer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 45. PerkinElmer Inc. (United States) Revenue: by Geography 2019
  • Figure 46. Global Platelet Function Testing: by Type USD Million (2020-2025)
  • Figure 47. Global Platelet Function Testing: by Application USD Million (2020-2025)
  • Figure 48. Global Platelet Function Testing: by Testing Type USD Million (2020-2025)
  • Figure 49. Global Platelet Function Testing: by End-Use USD Million (2020-2025)
  • Figure 50. South America Platelet Function Testing Share (%), by Country
  • Figure 51. Asia Pacific Platelet Function Testing Share (%), by Country
  • Figure 52. Europe Platelet Function Testing Share (%), by Country
  • Figure 53. MEA Platelet Function Testing Share (%), by Country
  • Figure 54. North America Platelet Function Testing Share (%), by Country
  • Figure 55. Global Platelet Function Testing: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Fresenius (Germany)
  • Siemens (Germany)
  • TERUMO BCT, INC. (United States)
  • Haemonetics Corporation (United States)
  • AggreDYNE (United States)
  • Helena Laboratories (United States)
  • Sysmex Corporation (Japan)
  • Haemochrom Diagnostica GmbH (Germany)
  • Pathway Diagnostics Limited (United Kingdom)
  • LABiTec LAbor BioMedical Technologies GmbH (Germany)
  • Thermo Fisher Scientific (United States)
  • Quest Diagnostics Incorporated (United States)
  • PerkinElmer Inc. (United States)
Additional players considered in the study are as follows:
WerfenLife, S.A. (Spain) , Matis Medical Inc. (United States) , Chrono-log Corporation (United States) , Drucker Diagnostics (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation